Actively Recruiting
Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
Led by RenJi Hospital · Updated on 2025-05-29
20
Participants Needed
1
Research Sites
60 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will use 18F-FAPI PET/CT to study myocardial fibrosis in patients diagnosed with myocardial infarction-associated ventricular aneurysm (MI-VA). Participants will receive the PET/CT scan during hospital stay, as well as serial echocardiography and telephonic follow-ups. Analysed will focus on the characterization of myocardial fibrosis and its correlations with the clinical prognosis in the patients.
CONDITIONS
Official Title
Fibrosis Assessment in Myocardial Infarction-associated Ventricular Aneurysm
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 18-75 years old
- Diagnosed with STEMI or NSTEMI (ACC/AHA guidelines)
- Half male and half female
- Undergo coronary angiography and PCI treatment
- Receive echocardiography or cardiac MRI to identify a ventricular aneurysm
- Provide written informed consent
You will not qualify if you...
- Under 18 years old
- Pregnant or breastfeeding
- History of allergy to radio tracers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Renji Hospital
Shanghai, China, 200127
Actively Recruiting
Research Team
Z
ZHIGUO ZOU, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here